Zhongping Su

1.1k total citations · 1 hit paper
20 papers, 736 citations indexed

About

Zhongping Su is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Zhongping Su has authored 20 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Zhongping Su's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Cardiac Ischemia and Reperfusion (3 papers) and Mesenchymal stem cell research (2 papers). Zhongping Su is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Cardiac Ischemia and Reperfusion (3 papers) and Mesenchymal stem cell research (2 papers). Zhongping Su collaborates with scholars based in China, United States and Japan. Zhongping Su's co-authors include Ting Zhao, Qiang You, Yingchang Li, Xiaoren Zhang, Ling Tao, Xianmin Mu, Wei Sun, Jinshun Pan, Yaqing Wang and Pengyu Zong and has published in prestigious journals such as Nature Communications, Neuron and European Journal of Pharmacology.

In The Last Decade

Zhongping Su

19 papers receiving 729 citations

Hit Papers

Chitinase-3 like-protein-1 function and its role in diseases 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongping Su China 13 388 136 115 105 71 20 736
Lucia Longhitano Italy 18 390 1.0× 94 0.7× 140 1.2× 60 0.6× 63 0.9× 44 846
Janet Beckmann Germany 9 347 0.9× 211 1.6× 113 1.0× 61 0.6× 91 1.3× 10 764
Chunlin Yang China 15 444 1.1× 179 1.3× 105 0.9× 97 0.9× 49 0.7× 43 783
Knut Fälker Sweden 11 198 0.5× 127 0.9× 108 0.9× 80 0.8× 68 1.0× 13 599
Hao Guo China 17 304 0.8× 79 0.6× 119 1.0× 98 0.9× 69 1.0× 61 678
Kenneth Cheung Hong Kong 15 328 0.8× 110 0.8× 104 0.9× 102 1.0× 41 0.6× 28 674
Jun Yao China 14 426 1.1× 175 1.3× 81 0.7× 110 1.0× 89 1.3× 28 904
Georgia Dalagiorgou Greece 16 373 1.0× 69 0.5× 98 0.9× 92 0.9× 107 1.5× 24 825
Roberto Bomprezzi United States 12 396 1.0× 212 1.6× 151 1.3× 123 1.2× 111 1.6× 24 973
Camilla Cerutti United Kingdom 9 287 0.7× 105 0.8× 167 1.5× 135 1.3× 51 0.7× 20 766

Countries citing papers authored by Zhongping Su

Since Specialization
Citations

This map shows the geographic impact of Zhongping Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongping Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongping Su more than expected).

Fields of papers citing papers by Zhongping Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongping Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongping Su. The network helps show where Zhongping Su may publish in the future.

Co-authorship network of co-authors of Zhongping Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongping Su. A scholar is included among the top collaborators of Zhongping Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongping Su. Zhongping Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Haozhe, Yiming Zhou, Jinghui Guo, et al.. (2023). Elevated extracellular calcium ions accelerate the proliferation and migration of HepG2 cells and decrease cisplatin sensitivity. Journal of Biomedical Research. 37(5). 340–340. 3 indexed citations
3.
Xu, Yujie, Haozhe Xu, Ling Tao, et al.. (2023). Inhibitor of nuclear factor kappa B kinase subunit epsilon regulates murine acetaminophen toxicity via RIPK1/JNK. Cell Biology and Toxicology. 39(6). 2709–2724. 2 indexed citations
4.
Zhao, Ting, Jianming Zeng, Yujie Xu, et al.. (2022). Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming. Theranostics. 12(16). 6989–7008. 46 indexed citations
5.
Zong, Pengyu, Jianlin Feng, Zhichao Yue, et al.. (2022). Functional coupling of TRPM2 and extrasynaptic NMDARs exacerbates excitotoxicity in ischemic brain injury. Neuron. 110(12). 1944–1958.e8. 67 indexed citations
6.
Li, Peng, Boxun Liu, Xiaoguang Wu, et al.. (2022). Perirenal adipose afferent nerves sustain pathological high blood pressure in rats. Nature Communications. 13(1). 3130–3130. 29 indexed citations
7.
Li, Mengjing, Ling Tao, Fengmeng Teng, et al.. (2021). CD5L deficiency attenuate acetaminophen-induced liver damage in mice via regulation of JNK and ERK signaling pathway. Cell Death Discovery. 7(1). 342–342. 6 indexed citations
8.
Wang, Yaqing, Lu‐Yang Wang, Zhongping Su, et al.. (2021). POU2AF1 promotes MSCs adipogenesis by inhibiting HDAC1 expression. Adipocyte. 10(1). 251–263. 6 indexed citations
9.
Zhang, Chen, Shi Xiao, Zhongping Su, et al.. (2021). CD36 deficiency ameliorates drug-induced acute liver injury in mice. Molecular Medicine. 27(1). 15 indexed citations
10.
Zhao, Ting, Zhongping Su, Yingchang Li, Xiaoren Zhang, & Qiang You. (2020). Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduction and Targeted Therapy. 5(1). 201–201. 326 indexed citations breakdown →
11.
Li, Xiang, Chen Zhang, Ting Zhao, et al.. (2020). Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 172–172. 93 indexed citations
12.
Su, Zhongping, Pengyu Zong, Ji Chen, et al.. (2020). Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling. Journal of Cellular and Molecular Medicine. 24(21). 12476–12490. 18 indexed citations
13.
Li, Chengzong, et al.. (2019). Cardioprotection of hydralazine against myocardial ischemia/reperfusion injury in rats. European Journal of Pharmacology. 869. 172850–172850. 14 indexed citations
14.
Wang, Tao, Bolei Cai, Mingchao Ding, et al.. (2019). c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity. The American Journal of the Medical Sciences. 358(3). 235–242. 35 indexed citations
15.
Zuo, Zhi, Mingyue Ji, Kun Zhao, et al.. (2019). CD47 Deficiency Attenuates Isoproterenol-Induced Cardiac Remodeling in Mice. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 16 indexed citations
16.
Peng, Cheng, et al.. (2019). Study on Connective Tissue Growth Factor Expressed in Patients with ST-Segment Elevation Myocardial Infarction.. PubMed. 35(4). 355–359. 1 indexed citations
17.
Su, Zhongping, Tianhua Xu, Yaqing Wang, et al.. (2019). Low‑intensity pulsed ultrasound promotes apoptosis and inhibits angiogenesis via p38 signaling‑mediated endoplasmic reticulum stress in human endothelial cells. Molecular Medicine Reports. 19(6). 4645–4654. 24 indexed citations
18.
Wang, Yaqing, Li Jiang, Tianhua Xu, et al.. (2019). p38 MAPK signaling is a key mediator for low-intensity pulsed ultrasound (LIPUS) in cultured human omental adipose-derived mesenchymal stem cells.. PubMed. 11(1). 418–429. 12 indexed citations
19.
Gu, Yang, Man Luo, Yong Li, et al.. (2018). Bcl6 knockdown aggravates hypoxia injury in cardiomyocytes via the P38 pathway. Cell Biology International. 43(2). 108–116. 17 indexed citations
20.
Liang, Liang, Jun Wang, Yuming Zhang, et al.. (2015). Transdifferentiation of bone marrow-derived mesenchymal stem cells into salivary gland-like cells using a novel culture method. Biotechnology Letters. 37(7). 1505–1513. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026